SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-051721
Filing Date
2022-04-28
Accepted
2022-04-28 09:00:44
Documents
18
Period of Report
2022-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213863d1_8k.htm   iXBRL 8-K 35056
2 EXHIBIT 10.1 tm2213863d1_ex10-1.htm EX-10.1 20670
3 EXHIBIT 10.2 tm2213863d1_ex10-2.htm EX-10.2 20416
4 EXHIBIT 99.1 tm2213863d1_ex99-1.htm EX-99.1 35277
8 GRAPHIC image_001.gif GRAPHIC 7088
9 GRAPHIC image_001.jpg GRAPHIC 5677
10 GRAPHIC tm2213863d1_ex99-1img001.jpg GRAPHIC 11598
  Complete submission text file 0001104659-22-051721.txt   346207

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA srne-20220428.xsd EX-101.SCH 3069
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20220428_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20220428_pre.xml EX-101.PRE 22619
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2213863d1_8k_htm.xml XML 3486
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 22862494
SIC: 2836 Biological Products, (No Diagnostic Substances)